← back to search

Karen D. Corbin

Hochschule Düsseldorf University of Applied Sciences · DE
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Diet and metabolism studies, Gut microbiota and health, Diabetes Management and Research, and Liver Disease Diagnosis and Treatment.
h-index
21
citations
2,501
works
109
NIH funding
primary concept
Medicine
email

Recent publications

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
Diabetes Care 2025cited by 181position: middledoi
Targeting the Gut Microbiota’s Role in Host Energy Absorption With Precision Nutrition Interventions for the Prevention and Treatment of Obesity
Nutrition Reviews 2025cited by 6position: firstdoi
Nutrition therapy in the era of automated insulin delivery
Frontiers in Endocrinology 2025cited by 0position: middledoi
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
Clinical Gastroenterology and Hepatology 2023cited by 18position: middledoi
An Overview of Diet and Physical Activity for Healthy Weight in Adolescents and Young Adults with Type 1 Diabetes: Lessons Learned from the ACT1ON Consortium
Nutrients 2023cited by 5position: middledoi
Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity
Journal of Nutrition 2022cited by 31position: middledoi
Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results
Diabetes Obesity and Metabolism 2022cited by 24position: middledoi
Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from <scp>VERTIS CV</scp> , a randomized trial of the <scp>sodium‐glucose cotransporter‐2</scp> inhibitor ertugliflozin
Diabetes Obesity and Metabolism 2022cited by 13position: firstdoi
Relationship Between Moderate-to-Vigorous Physical Activity and Glycemia Among Young Adults with Type 1 Diabetes and Overweight or Obesity: Results from the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study
Diabetes Technology & Therapeutics 2022cited by 6position: middledoi
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort
Clinical Gastroenterology and Hepatology 2021cited by 67position: middledoi
Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort
The FASEB Journal 2015cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard E. Pratley · AdventHealth Translational Research Institute4 papers (2022–2023)Daria Igudesman · AdventHealth Orlando4 papers (2022–2025)Elizabeth J. Mayer‐Davis · University of North Carolina at Chapel Hill4 papers (2022–2025)David M. Maahs · University of Adelaide4 papers (2022–2025)Ananta Addala · Stanford University2 papers (2022–2023) · 2 papers (2022–2022)Michael R. Kosorok · University of North Carolina at Chapel Hill2 papers (2022–2022)Franziska K. Bishop · Palo Alto University2 papers (2023–2025)Dessi P. Zaharieva · Stanford University2 papers (2022–2023)Michael C. Riddell · York University2 papers (2022–2023)Joan Thomas · Wake Forest University2 papers (2022–2022)Franklin R. Muntis · University of Louisville1 papers (2023–2023)Brian W. Pence · San Francisco General Hospital1 papers (2022–2022)Miguel Malespin · University of Florida1 papers (2021–2021)Joan K. Bardsley · MedStar Heart & Vascular Institute1 papers (2025–2025)Caroline M. Apovian · Brigham and Women's Hospital1 papers (2025–2025)Kyle S. Burger · Eunice Kennedy Shriver National Institute of Child Health and Human Development1 papers (2022–2022)Stephanie Watkins · University Hospitals Birmingham NHS Foundation Trust1 papers (2021–2021)Christopher P. Cannon · Harvard University1 papers (2022–2022)Raveendhara R. Bannuru · Tufts University1 papers (2025–2025)